| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
4,254 |
2,958 |
$21K |
| 80053 |
Comprehensive metabolic panel |
13,976 |
9,254 |
$12K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,832 |
5,460 |
$10K |
| 87186 |
|
2,278 |
1,396 |
$9K |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
16,809 |
10,304 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,370 |
9,795 |
$5K |
| 80061 |
Lipid panel |
7,101 |
4,994 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,257 |
4,341 |
$3K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
955 |
247 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
254 |
114 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
817 |
287 |
$2K |
| 82607 |
|
4,871 |
3,331 |
$2K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
210 |
102 |
$2K |
| 87077 |
|
2,408 |
1,537 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,347 |
2,767 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,499 |
856 |
$1K |
| 84480 |
|
887 |
674 |
$1K |
| 80164 |
|
696 |
518 |
$1K |
| 81003 |
|
6,298 |
4,177 |
$1K |
| 82728 |
|
1,827 |
1,173 |
$738.86 |
| 87088 |
|
2,459 |
1,578 |
$720.04 |
| 36415 |
Collection of venous blood by venipuncture |
17,022 |
10,474 |
$703.58 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
310 |
154 |
$647.50 |
| 82746 |
|
2,192 |
1,477 |
$585.94 |
| 84436 |
|
822 |
642 |
$567.95 |
| 82140 |
|
476 |
341 |
$535.61 |
| 87481 |
|
776 |
306 |
$521.25 |
| 84439 |
|
2,535 |
1,772 |
$494.47 |
| 84479 |
|
628 |
501 |
$426.70 |
| 84153 |
|
189 |
138 |
$390.91 |
| 87150 |
|
21 |
17 |
$386.05 |
| 87640 |
|
478 |
325 |
$373.17 |
| 87500 |
|
357 |
273 |
$340.12 |
| 83735 |
|
1,283 |
822 |
$323.32 |
| 87653 |
|
463 |
316 |
$322.95 |
| 82652 |
|
359 |
283 |
$252.13 |
| 83540 |
|
2,197 |
1,403 |
$250.56 |
| 83550 |
|
1,932 |
1,231 |
$250.00 |
| 87641 |
|
365 |
250 |
$211.16 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
250 |
179 |
$191.93 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
692 |
393 |
$164.22 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
648 |
394 |
$106.22 |
| 84481 |
|
119 |
97 |
$61.45 |
| 82570 |
|
195 |
148 |
$56.72 |
| 82044 |
|
199 |
148 |
$50.58 |
| 83880 |
|
72 |
50 |
$28.47 |
| 85045 |
|
71 |
50 |
$16.60 |
| 85610 |
|
51 |
24 |
$11.50 |
| 82248 |
|
23 |
13 |
$6.25 |
| 84550 |
|
34 |
24 |
$2.93 |
| 85651 |
|
42 |
30 |
$0.00 |
| G2024 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source |
23 |
15 |
$0.00 |
| 86140 |
|
33 |
20 |
$0.00 |
| 87563 |
|
21 |
17 |
$0.00 |